Litcius/Paper detail

SCOPE 2 – Still Answering the Unanswered Questions in Oesophageal Radiotherapy? SCOPE 2: a Randomised Phase II/III Trial to Study Radiotherapy Dose Escalation in Patients with Oesophageal Cancer Treated with Definitive Chemoradiation with an Embedded Phase II Trial for Patients with a Poor Early Response using Positron Emission Tomography/Computed Tomography

S Bridges, B Thomas, G. Radhakrishna, M. Hawkins, A Holborow, Chris Hurt, Saptarshi Mukherjee, Lisette Nixon, T. Crosby, Sarah Gwynne

2022Clinical Oncology20 citationsDOIOpen Access PDF

Topics & Concepts

MedicineRadiation therapyScope (computer science)ChemoradiotherapyRandomized controlled trialClinical trialOncologySchema (genetic algorithms)Medical physicsInternal medicineMachine learningComputer scienceProgramming languageEsophageal Cancer Research and TreatmentLung Cancer Diagnosis and TreatmentGastric Cancer Management and Outcomes
SCOPE 2 – Still Answering the Unanswered Questions in Oesophageal Radiotherapy? SCOPE 2: a Randomised Phase II/III Trial to Study Radiotherapy Dose Escalation in Patients with Oesophageal Cancer Treated with Definitive Chemoradiation with an Embedded Phase II Trial for Patients with a Poor Early Response using Positron Emission Tomography/Computed Tomography | Litcius